Rachel Park
Areas of Focus
Overview
Rachel Park is a senior counsel in Crowell & Moring’s Washington, D.C. office and a member of the firm’s Health Care Group. She advises clients on a wide array of health care matters, including Medicare and Medicaid reimbursement, managed care litigation, and health care fraud investigations and oversight. Prior to joining Crowell, she served for 24 years at the U.S. Department of Health and Human Services (HHS), most recently as principal deputy general counsel, the highest-level nonpolitical appointee in the HHS Office of the General Counsel.
Career & Education
- New York University School of Law, J.D., 1993
- Swarthmore College, B.A., chemistry and psychology, 1988
- New York
- U.S. Court of Appeals for the Third Circuit
- U.S. District Court for the Northern District of New York
- *Admitted in New York Only. Practicing under the Supervision of D.C. Bar Members.
Professional Activities and Memberships
- Member, American Health Law Association
Rachel's Insights
Client Alert | 7 min read | 03.19.26
New Federal Guidance for Organ Procurement
2026 will prove to be a pivotal year for organ procurement organizations (OPOs). For the first time, the impact of the Center for Medicare and Medicaid Services’ (CMS) 2020 outcome measures will be fully felt, as the year marks the end of the first certification cycle governed by the new benchmarks. In the meantime, OPOs are challenging the 2020 rule in several federal lawsuits and, as that litigation progresses, CMS is accepting comments on a new proposed rule, which we discussed in a prior alert.
Client Alert | 10 min read | 02.13.26
What Organ Procurement Organizations Need to Know About CMS's New Proposed Rule
Client Alert | 2 min read | 02.03.26
Insights
Wilmer Rehires Trump Transition Attorney, Crowell Adds To Health Care Team
|09.29.25
The National Law Journal
Rachel's Insights
Client Alert | 7 min read | 03.19.26
New Federal Guidance for Organ Procurement
2026 will prove to be a pivotal year for organ procurement organizations (OPOs). For the first time, the impact of the Center for Medicare and Medicaid Services’ (CMS) 2020 outcome measures will be fully felt, as the year marks the end of the first certification cycle governed by the new benchmarks. In the meantime, OPOs are challenging the 2020 rule in several federal lawsuits and, as that litigation progresses, CMS is accepting comments on a new proposed rule, which we discussed in a prior alert.
Client Alert | 10 min read | 02.13.26
What Organ Procurement Organizations Need to Know About CMS's New Proposed Rule
Client Alert | 2 min read | 02.03.26
